The DOI matches its Crossref record; 138 of the 139 references it cites were found in a registry or an index.
ILLEGAL OR LEGITIMATE USE? PRECURSOR COMPOUNDS TO AMPHETAMINE AND METHAMPHETAMINE
Abstract
The interpretation of methamphetamine and amphetamine positive test results in biological samples is a challenge to clinical and forensic toxicology for several reasons. The effects of pH and dilution of urine samples and the knowledge about legitimate and illicit sources have to be taken into account. Besides a potentially legal prescription of amphetamines, many substances metabolize to methamphetamine or amphetamine in the body: amphetaminil, benzphetamine, clobenzorex, deprenyl, dimethylamphetamine, ethylamphetamine, famprofazone, fencamine, fenethylline, fenproporex, furfenorex, mefenorex, mesocarb, and prenylamine. Especially the knowledge of potential origins of methamphetamine and amphetamine turns out to be very important to prevent a misinterpretation of the surrounding circumstances and to prove illegal drug abuse. In this review, potential precursor compounds are described, including their medical use and major clinical effects and their metabolic profiles, as well as some clues which help to identify the sources.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Metabolites of cocaine, especially benzoylecgonine, however, are longer lasting (~6 hours) with long periods to complete elimination following repeated, high-dose administrations prior to abstinence (22).”
From Clinical management of psychostimulant withdrawal: review of the evidence (2023) · cites this paper as [22]
Citations
Cites
Disposition of Toxic Drugs and Chemicals in Man
Baselt, R. C. (1982) · Medical Entomology and Zoology · Cited by 1,815
Bunney, W. E., Hippius, H., Laakmann, G., & Schmauß, M. (1990) · Springer eBooks · doi:10.1007/978-3-642-74034-3 · Cited by 1,523
Martindale. The Extra Pharmacopoeia.
(1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-5-687_2 · Cited by 1,113
Disposition of Toxic Drugs and Chemicals in Man
Christensen, H. (1983) · Forensic Science International · doi:10.1016/0379-0738(83)90025-7 · Cited by 566
Ellenhorn's Medical Toxicology: Diagnosis and Treatment of Human Poisoning
Rodgers, G. C. (1997) · JAMA · doi:10.1001/jama.1997.03550140095052 · Cited by 395
Deprenyl is metabolized to methamphetamine and amphetamine in man.
Reynolds, G. P., Elsworth, J. D., Blau, K., Sandler, M., Lees, A. J., & Stern, G. M. (1978) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1978.tb00883.x · Cited by 285
Metabolism of [14C]methamphetamine in man, the guinea pig and the rat
Caldwell, J., Dring, L. G., & Williams, R. T. (1972) · Biochemical Journal · doi:10.1042/bj1290011 · Cited by 262
The metabolic fate of amphetamine in man and other species
Dring, L. G., Smith, R. L., & Williams, R. T. (1970) · Biochemical Journal · doi:10.1042/bj1160425 · Cited by 248
Urinary excretion kinetics of amphetamine in man
Beckett, A. H., & Rowland, M. (1965) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1965.tb07575.x · Cited by 209
Nakahara, Y., Takahashi, K., & Kikura, R. (1995) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.18.1223 · Cited by 202
Research works printed but not linked: 28
- 1996, Physician's Desk Reference
- Cody J, 1993, Forensic Sci. Rev., 5, 109
- Cody J, 1994, Forensic Sci. Rev., 6, 81
- Hutchaleelaha A., 1994, Drug Metab. Dispos., 22, 406
- Meyer-Probst B., 1976, Psychiatr. Neurol. Med. Psychol., 28, 491
- Besserer K, 1972, Drug Res., 22, 1737
- Honecker H, 1975, Int. J. Clin. Pharmacol. Biopharm., 12, 121
- Beyer K., 1971, Dtsch. Apoth. Ztg., 111, 677
- Hoffmann H, 1971, Dtsch. Apoth. Ztg., 111, 680
- Honecker V H., 1975, Drug Res., 25, 442
- Glasson B., 1971, Drug Res., 21, 1985
- Knoll J, 1986, J. Neural Transmiss., 22, 75
- Szebeni G., 1995, Acta Physiol. Hung., 83, 135
- Heinonen E. H., 1989, Acta Neurol. Scand., 126, 93
- Delbeke F. T., 1986, Drug Res., 36, 1413
- Mrongovius R., 1984, Eur. J. Med. Chem. Chim. Therap., 19, 161
- Mallol J., 1974, Drug Res., 24, 1301
- Iffland R, 1982, Arch. Kriminol., 169, 81
- Goenechea S., 1984, Arch. Kriminol., 173, 97
- Rücker G., 1988, Drug Res., 38, 497
- Boissier J. R., 1968, Ann. Pharm. Fr., 26, 215
- Beyer G., 1980, Med. Welt., 31, 306
- Blum J. E, 1969, Drug Res., 19, 748
- Leary W. P., 1976, Curr. Therap. Res. Clin. Exp., 19, 180
- Manning A., 1985, Adv. Mycardiol., 6, 515
- Gietl Y., 1989, Drug Res., 39, 853
- Hornke I., 1970, Drug Res., 20, 791
- Jefferson J. W, 1992, J. Clin. Psychiatry, 53, 450
Cited by
Sorted by citations
Chiral Toxicology: It's the Same Thing…Only Different
Smith, S. W. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp097 · Cited by 616
Kræmer, T., & Maurer, H. H. (2002) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200204000-00009 · Cited by 233
Peters, F. T., Schaefer, S., Staack, R. F., Kræmer, T., & Maurer, H. H. (2003) · Journal of Mass Spectrometry · doi:10.1002/jms.483 · Cited by 169
Clinical Pharmacokinetics of Amfetamine and Related Substances
de la Torre, R., Farr, M., Navarro, M., Pacifici, R., Zuccaro, P., & Pichini, S. (2004) · Clinical Pharmacokinetics · doi:10.2165/00003088-200443030-00002 · Cited by 154
Analytical pitfalls in hair testing
Mußhoff, F., & Madea, B. (2007) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-007-1288-x · Cited by 144
Treatment of obesity: an update on anti‐obesity medications
Halpern, A., & Mancini, M. C. (2003) · Obesity Reviews · doi:10.1046/j.1467-789x.2003.00083.x · Cited by 115
Bioanalytical procedures for determination of drugs of abuse in blood
Kræmer, T., & Paul, L. D. (2007) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-007-1271-6 · Cited by 104
Enantiomeric profiling of chiral illicit drugs in a pan-European study
Castrignanò, E., Yang, Z., Bade, R., Baz‐Lomba, J. A., Castiglioni, S., Causanilles, A., Covaci, A., Gracia‐Lor, E., Hernández, F. J., Kinyua, J., et al. (2017) · Water Research · doi:10.1016/j.watres.2017.11.051 · Cited by 101
Screening for drugs of abuse: which matrix, oral fluid or urine?
Allen, K. R. (2011) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2011.011116 · Cited by 97
Carmo, H., Hengstler, J. G., de Boer, D., Ringel, M. T., Remião, F., Carvalho, F. D., Fernandes, E. G. R., dos Reys, L. A., Oesch, F., & Bastos, M. D. L. (2004) · Toxicology · doi:10.1016/j.tox.2004.07.004 · Cited by 86
Rasmussen, L. N., OLSEN, K., & Johansen, S. S. (2006) · Journal of Chromatography B · doi:10.1016/j.jchromb.2006.05.011 · Cited by 84
Peters, F. T., Kræmer, T., & Maurer, H. H. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.9.1472 · Cited by 84
Kankaanpää, A., Gunnar, T., Ariniemi, K., Lillsunde, P. M., Mykkänen, S., & Seppαlä, T. (2004) · Journal of Chromatography B · doi:10.1016/j.jchromb.2004.07.035 · Cited by 83
Shahvandi, S. K., Banitaba, M. H., & Ahmar, H. (2018) · Talanta · doi:10.1016/j.talanta.2018.02.115 · Cited by 79
Pharmacological treatment of obesity
Mancini, M. C., & Halpern, A. (2006) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302006000200024 · Cited by 73
Pilgrim, J. L., Gerostamoulos, D., & Drummer, O. H. (2010) · Forensic Science Medicine and Pathology · doi:10.1007/s12024-010-9188-3 · Cited by 71
Peters, F. T., Samyn, N., Wahl, M., Kræmer, T., Boeck, G. D., & Maurer, H. H. (2003) · Journal of Analytical Toxicology · doi:10.1093/jat/27.8.552 · Cited by 67
Clinical Effects and Management of Methamphetamine Abuse
Romanelli, F., & Smith, K. M. (2006) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.26.8.1148 · Cited by 69
Jones, A. W., Holmgren, A., & Kugelberg, F. C. (2007) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e31803d3c04 · Cited by 64
Steuer, A. E., Meyer, M. R., & Maurer, H. H. (2012) · Journal of Chromatography A · doi:10.1016/j.chroma.2012.07.045 · Cited by 62
Stereoselectivity in the human metabolism of methamphetamine
Li, L., Everhart, T., Jacob, P., Jones, R. T., & Mendelson, J. E. (2009) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03576.x · Cited by 60
Wang, S.-M., Wang, T.-C., & Giang, Y. (2004) · Journal of Chromatography B · doi:10.1016/j.jchromb.2004.11.027 · Cited by 55
Cody, J. T. (2002) · Journal of Occupational and Environmental Medicine · doi:10.1097/00043764-200205000-00012 · Cited by 55
Tratamento Farmacológico da Obesidade
Mancini, M. C., & Halpern, A. (2002) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302002000500003 · Cited by 49
Wang, T., Shen, B., Shi, Y., Xiang, P., & Yu, Z. (2014) · Forensic Science International · doi:10.1016/j.forsciint.2014.11.009 · Cited by 49
Golub, M. S., Costa, L. G., Crofton, K. M., Frank, D. A., Fried, P. A., Gladen, B. C., Henderson, R. F., Liebelt, E. L., Lusskin, S. I., Marty, S., et al. (2005) · Birth Defects Research Part B Developmental and Reproductive Toxicology · doi:10.1002/bdrb.20048 · Cited by 49
Driving Under the Influence of Amphetamine‐Like Drugs
Mußhoff, F., & Madea, B. (2012) · Journal of Forensic Sciences · doi:10.1111/j.1556-4029.2012.02055.x · Cited by 44
Liu, J., & Liu, R. H. (2002) · Journal of Biochemical and Biophysical Methods · doi:10.1016/s0165-022x(02)00136-7 · Cited by 44
Kon, A. A., Pretzlaff, R. K., & Marcin, J. P. (2004) · Health Policy · doi:10.1016/j.healthpol.2003.12.006 · Cited by 43
Pharmacological Approaches for the Treatment of Obesity
Fern??ndez-L??pez, J.-A., Remesar, X., Foz, M., & Alemany, M. (2002) · Drugs · doi:10.2165/00003495-200262060-00005 · Cited by 42
Metabolic, toxicological, and safety considerations for drugs used to treat ADHD
Duong, S., Chung, K., & Wigal, S. B. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.671295 · Cited by 42
Verstraete, A., & Heyden, F. V. (2005) · Journal of Analytical Toxicology · doi:10.1093/jat/29.5.359 · Cited by 42
Models of intervention and care for psychostimulant users
Baker, A., Lee, N., & Jenner, L. (2004) · Cited by 42
Newmeyer, M. N., Concheiro, M., & Huestis, M. A. (2014) · Journal of Chromatography A · doi:10.1016/j.chroma.2014.06.096 · Cited by 41
Analysis of methamphetamine and its metabolites in hair
Takayama, N., Iio, R., Tanaka, S., Chinaka, S., & Hayakawa, K. (2003) · Biomedical Chromatography · doi:10.1002/bmc.225 · Cited by 40
Choi, K., Kim, J., Jang, Y. O., & Chung, D. S. (2009) · Electrophoresis · doi:10.1002/elps.200800829 · Cited by 39
Peters, F. T., Samyn, N., Kræmer, T., Riedel, W. J., & Maurer, H. H. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.081547 · Cited by 39
Clinical management of psychostimulant withdrawal: review of the evidence
Li, M. J., & Shoptaw, S. J. (2023) · Addiction · doi:10.1111/add.16093 · Cited by 39
Carmo, H., de Boer, D., Remião, F., Carvalho, F. D., dos Reys, L. A., & Bastos, M. D. L. (2004) · Journal of Chromatography B · doi:10.1016/j.jchromb.2004.08.026 · Cited by 36
Prodrugs of New Psychoactive Substances (NPS): A New Challenge
Elliott, S. P., Holdbrook, T., & Brandt, S. D. (2020) · Journal of Forensic Sciences · doi:10.1111/1556-4029.14268 · Cited by 33
Wang, T., Xu, C., Xu, S., Gao, L., Blaženović, I., Ji, J., Wang, J., & Sun, X. (2021) · Addiction Biology · doi:10.1111/adb.13062 · Cited by 32
Drugged driving arrests in Norway before and after the implementation of per se law
Vindenes, V., Boix, F., Koksæter, P., Strand, M. C., Bachs, L. C., Mørland, J. G., & Gjerde, H. (2014) · Forensic Science International · doi:10.1016/j.forsciint.2014.10.038 · Cited by 31
Hädener, M., Bruni, P. S., Weinmann, W., Frübis, M., & König, S. (2016) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-016-0056-1 · Cited by 29
Leis, H., Rechberger, G. N., Fauler, G., & Windischhofer, W. (2003) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.949 · Cited by 27
Jeong, E. S., Kim, S., Cha, E., Lee, K. M., Kim, H. J., Lee, S., Kwon, O., & Lee, J. (2015) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.7113 · Cited by 27
Sethi, S., Martens, J., & Bhushan, R. (2020) · Biomedical Chromatography · doi:10.1002/bmc.4990 · Cited by 27
Methamphetamine: Putting the Brakes on Speed
Gettig, J. P., Grady, S. E., & Nowosadzka, I. (2006) · The Journal of School Nursing · doi:10.1177/105984050602200202 · Cited by 26
Subiah, C. O., Mabandla, M. V., Phulukdaree, A., Chuturgoon, A. A., & Daniels, W. M. U. (2012) · Metabolic Brain Disease · doi:10.1007/s11011-012-9297-7 · Cited by 24
Exposures associated with clandestine methamphetamine drug laboratories in Australia
Wright, J., Edwards, J. W., & Walker, G. (2016) · Reviews on Environmental Health · doi:10.1515/reveh-2016-0017 · Cited by 24
Detection of β-methylphenethylamine, a novel doping substance, by means of UPLC/MS/MS
Chołbiński, P., Wicka, M., Kowalczyk, K., Jarek, A., Kaliszewski, P., Pokrywka, A., Bulska, E., & Kwiatkowska, D. (2014) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-014-7728-5 · Cited by 24
Losacker, M., Krämer, M., Philipsen, A., Dücker, K., Dreimüller, N., Engelmann, J., Roehrich, J., & Heß, C. (2021) · Metabolites · doi:10.3390/metabo11080521 · Cited by 23
Schwelm, H. M., Grumann, C., Auwärter, V., & Neukamm, M. A. (2020) · Drug Testing and Analysis · doi:10.1002/dta.2886 · Cited by 21
Niebel, A., Westendorf, L., Krumbiegel, F., Härtwig, S., Parr, M. K., & Tsokos, M. (2021) · Drug Testing and Analysis · doi:10.1002/dta.3150 · Cited by 20
Richter, L. H. J., Beck, A., Flockerzi, V., Maurer, H. H., & Meyer, M. R. (2018) · Toxicology Letters · doi:10.1016/j.toxlet.2018.11.007 · Cited by 20
Jafari, B., Gharbavi, M., Baghdadchi, Y., Manjili, H. K., Mahmoudi, J., Anarkooli, I. J., Amiri, S., & Hosseini, M. (2022) · Behavioural Neurology · doi:10.1155/2022/4825472 · Cited by 19
Kræmer, T., Pflugmann, T., Bossmann, M., Kneller, N. M., Peters, F. T., Paul, L. D., Springer, D., Staack, R. F., & Maurer, H. H. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.05.009 · Cited by 19
Rashid, S. N. A., Rahim, A. S. A., Thali, M. J., & Flach, P. M. (2013) · Forensic Science Medicine and Pathology · doi:10.1007/s12024-012-9395-1 · Cited by 19
Niebel, A., Pragst, F., Krumbiegel, F., & Härtwig, S. (2021) · Forensic Science International · doi:10.1016/j.forsciint.2021.111148 · Cited by 18
The Therapeutic Potential of Amphetamine-like Psychostimulants
Pires, B., Rosendo, L. M., Brinca, A. T., Simão, A. Y., Barroso, M., Rosado, T., & Gallardo, E. (2023) · Life · doi:10.3390/life13112180 · Cited by 19
Kim, J. Y., Suh, S., Park, J., & In, M. K. (2018) · Journal of Analytical Toxicology · doi:10.1093/jat/bky037 · Cited by 16
Gruner, J. A., Mathiasen, J. R., Flood, D. G., & Ga̧sior, M. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.178947 · Cited by 14
A Historical Overview Upon the Use of Amphetamine Derivatives in the Treatment of Obesity
Stăcescu, Ș., Hancu, G., Podar, D., Todea, Ș., & Tero-Vescan, A. (2020) · Journal of Pharmaceutical Care · doi:10.18502/jpc.v7i3.2355 · Cited by 14
Comiran, E., Souza, D. Z., Boehl, P. O., Mariotti, K. D. C., Pechansky, F., Duarte, P. D. C. A. V., Boni, R. B. D., Fröehlich, P. E., & Limberger, R. P. (2012) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e318263c6c5 · Cited by 13
Famprofazone Use Can Be Misinterpreted as Methamphetamine Abuse
Chan, K., Hsu, M., Tseng, C.-Y., & Chu, W.-L. (2010) · Journal of Analytical Toxicology · doi:10.1093/jat/34.6.347 · Cited by 13
Detection of abused drugs in urine by GC-MS
Hsu, M., Chen, D., & Liu, R. H. (2020) · Journal of Food and Drug Analysis · doi:10.38212/2224-6614.2600 · Cited by 13
Toxicology and Drugs of Abuse Testing at the Point of Care
Yang, J. M. (2001) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(18)30040-4 · Cited by 12
Joseph, A., Gangasani, J. K., Pawar, S. D., Hirlekar, B. U., Bharatam, P. V., Konda, S., Mudiam, M. K. R., Murty, U. S., Sahu, K., Dubey, S., et al. (2021) · Drug Testing and Analysis · doi:10.1002/dta.3171 · Cited by 11
Pharmacokinetics of Dexamphetamine in Acute Stroke
Martinsson, L., Yang, X., Beck, O., Wahlgren, N. G., & Eksborg, S. (2003) · Clinical Neuropharmacology · doi:10.1097/00002826-200309000-00012 · Cited by 11
Comiran, E., Barreto, F., Meneghini, L. Z., Carlos, G., Fröehlich, P. E., & Limberger, R. P. (2016) · Biomedical Chromatography · doi:10.1002/bmc.3812 · Cited by 11
Huang, W., Liu, C., Liu, R. H., & Tseng, Y. L. (2010) · Journal of Analytical Toxicology · doi:10.1093/jat/34.2.73 · Cited by 11
Hemmer, S., Wagmann, L., & Meyer, M. R. (2021) · Archives of Toxicology · doi:10.1007/s00204-021-03135-8 · Cited by 10
A farmacoterapia no tratamento da obesidade
de Oliveira, R. C., Barão, F. M., Ferreira, E., & Oliveira, A. F. M. (2009) · Americanae (AECID Library) · Cited by 10
Ermer, J. C., Corcoran, M., Lasseter, K. C., Marbury, T. C., Yan, B. M., & Martin, P. T. (2016) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000296 · Cited by 10
Interpretation of Pain Management Testing Results Using Case Examples
Sobolesky, P. M., Smith, B. E., Pesce, A. J., & Fitzgerald, R. L. (2018) · The Journal of Applied Laboratory Medicine · doi:10.1373/jalm.2017.024786 · Cited by 9
Pragst, F. (2025) · ChemTexts · doi:10.1007/s40828-024-00197-w · Cited by 8
Lee, S., You, I., Kim, M., Kwon, S., Hong, S., Kim, J., Jang, M., Oh, S.-M., Chung, K., Lee, S., et al. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.01.022 · Cited by 8
Gobble, C. P., Vikman, J., & Chickos, J. S. (2014) · Journal of Chemical & Engineering Data · doi:10.1021/je500358r · Cited by 8
Nielsen, M. K. K., Andersen, N. Z., Rasmussen, B. S., & Johansen, S. S. (2022) · Journal of Analytical Toxicology · doi:10.1093/jat/bkac103 · Cited by 7
Możdżeń, K., Kaleta, K., Murawska, A., Pośpiech, J., Panek, P., Lorkowska-Zawicka, B., & Bujak-Giżycka, B. (2023) · Folia Medica Cracoviensia · doi:10.24425/fmc.2023.145917 · Cited by 6
Neurodegeneration from Drugs and Aging‐Derived Free Radicals
Ramkissoon, A., Shapiro, A. M., Loniewska, M. M., & Wells, P. G. (2013) · Wiley eBooks · doi:10.1002/9781118355886.ch10 · Cited by 6
Helander, A., Andersson, A. K., & Villén, T. (2024) · Drug Testing and Analysis · doi:10.1002/dta.3690 · Cited by 5
A comparative analysis of protein targets of withdrawn cardiovascular drugs in human and mouse
Zhao, Y., Wang, J., Wang, Y., & Huang, J. (2012) · Journal of Clinical Bioinformatics · doi:10.1186/2043-9113-2-10 · Cited by 5
Toxicology of Specific Substances
Jones, A. W., Mußhoff, F., Kræmer, T., Steuer, A. E., Gerostamoulos, D., Drummer, O. H., Drasch, G. A., Balı́ková, M., Beyer, J., Teixeira, H. M., et al. (2014) · doi:10.1002/9781118570654.ch51 · Cited by 5
Electrochemiluminescent detection of doping drugs in sports using metal-organic frameworks (MOFs)
Xie, B., & Zhang, F. (2024) · International Journal of Electrochemical Science · doi:10.1016/j.ijoes.2024.100552 · Cited by 3
Uso de anfetamínicos por motoristas profissionais brasileiros: aspectos gerais
Leyton, V., Carvalho, D. V. C., de JESUS, M. D. G. S., & Muñoz, D. R. (2002) · Saúde Ética & Justiça · doi:10.11606/issn.2317-2770.v5i1-2p32-36 · Cited by 3
Chapter 8 Non-opioid analgesics
Kræmer, T., & Maurer, H. H. (2007) · Handbook of analytical separations · doi:10.1016/s1567-7192(06)06008-6 · Cited by 3
Drugs of Abuse (Including Designer Drugs)
Meyer, M. R., & Maurer, H. H. (2012) · doi:10.1002/9783527630905.ch16 · Cited by 3
Amphetamine and Methamphetamine
Barceloux, D. G. (2012) · doi:10.1002/9781118105955.ch1 · Cited by 3
Toxicology of Specific Substances
Jones, A. W., Mußhoff, F., Kræmer, T., Steuer, A. E., Gerostamoulos, D., Drummer, O. H., Drasch, G. A., Balı́ková, M., Beyer, J., Teixeira, H. M., et al. (2022) · doi:10.1002/9781119648628.ch52 · Cited by 3
Madoc‐Jones, I. (2008) · Glyndwr University Research Online (Glyndwr University) · doi:10.4324/9781843925705-18 · Cited by 2
Kwon, W., Kim, J. Y., Suh, S., & In, M. K. (2012) · Biomedical Chromatography · doi:10.1002/bmc.2752 · Cited by 2
Helander, A., Andersson, A. K., & Villén, T. (2025) · Drug Testing and Analysis · doi:10.1002/dta.3940 · Cited by 1
Rajkumar, P., Tang, R., Sapre, H., Zemlin, J., Deleray, V., Seo, J. I., Mohan, S., Xing, S., Gouda, H., Abiead, Y. E., et al. (2026) · Analytical Chemistry · doi:10.1021/acs.analchem.5c05301 · Cited by 2
Amphetamines, methylphenidate and excessive sleepiness
McCann, U. D. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511762697.037 · Cited by 1
Identificação de anfetamina em amostras de cabelo por imunofluorescência polarizada
Mariz, S. R., & Silva, O. A. (2003) · Revista Brasileira De Ciencias Farmaceuticas · doi:10.1590/s1516-93322003000100005 · Cited by 1
Nakano, S., Kamata, T., Kakehashi, H., Kamata, H., Sasaki, K., Matsuta, S., Shima, N., Miki, A., & Katagi, M. (2022) · Japanese Journal of Forensic Science and Technology · doi:10.3408/jafst.830 · Cited by 1
Investigating the Removal Efficiency of Fenton Reaction for Drugs in Municipal Wastewater
Bai, S., Wang, F., Liu, S., Chen, Y., Li, M., Liu, L., Xu, S., & Xu, J. (2024) · ChemistrySelect · doi:10.1002/slct.202400857 · Cited by 1
Neurobehavioral and molecular changes in rats exposed to either captagon or counterfeit captagon
Althobaiti, Y. S., AL-Shanbari, A. H., Alshoaibi, D. S., Khan, E., Alghamdi, H. A., Aljuaid, S. A., Alzilifi, A. A., Alsulimani, N. K., Alrizqi, O. A., Alkhalifa, T., et al. (2025) · Saudi Pharmaceutical Journal · doi:10.1007/s44446-025-00007-5 · Cited by 1
Defending Positive Amphetamine Results
Dasgupta, A. (2009) · Humana Press eBooks · doi:10.1007/978-1-60761-527-9_9 · Cited by 1
Verkehrsrecht und rechtsmedizinische Aufgaben
Berghaus, G., Graß, H., Friedel, B., Lappe, E., Madea, B., Mußhoff, F., & Reinhardt, G. (2003) · Springer eBooks · doi:10.1007/978-3-642-55866-5_10 · Cited by 1
Metadata
- Authors
- MUSSHOFF, F.
- Affiliations
- University of Bonn (DE)
- Corresponding author
- MUSSHOFF, F.
- ORCID
- MUSSHOFF, F.
- Venue
- Drug Metabolism Reviews
- Publisher
- Informa UK Limited
- Published
- 2000-01
- Volume
- 32
- Issue
- 1
- Pages
- 15-44
- ISSN
- 0360-2532 (ISSN-L)
- 1097-9883
- OpenAlex
- W2019322128
- Cited by
- 116
- References
- 139
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 3 · 2023: 2 · 2022: 6 · 2021: 6 · 2020: 6 · 2018: 4 · 2017: 1 · 2016: 5 · 2015: 2 · 2014: 7 · 2013: 3 · 2012: 11
- FWCI
- 7.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Drug Metabolism Reviews (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Pharmacological Effects and Assays
- Social Sciences › Sociology and Political Science › Doping in Sports
- Keywords
- amphetamine, methamphetamine, precursors, drug metabolites, urine drug testing, prescription drugs, drug metabolism, forensic toxicology, clinical toxicology, drug abuse
- MeSH terms
- Amphetamines, Animals, Benzphetamine, Furans, Hair, Humans, Methamphetamine, Pyrazoles, Selegiline, Sydnones, Theophylline, Pyrazolones
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review